What is the recommended treatment for bacterial vaginosis in a pregnant woman?

Treatment of Bacterial Vaginosis in Pregnant Women

For pregnant women with symptomatic bacterial vaginosis, treat with oral metronidazole 250 mg three times daily for 7 days or oral clindamycin 300 mg twice daily for 7 days. 1

Treatment Approach Based on Risk Status

Symptomatic Pregnant Women (All Risk Levels)

All symptomatic pregnant women should be tested and treated to relieve vaginal symptoms and potentially reduce adverse pregnancy outcomes. 1

Recommended regimens:

• Metronidazole 250 mg orally three times daily for 7 days 1
• Clindamycin 300 mg orally twice daily for 7 days 1

The lower metronidazole dose (250 mg vs. 500 mg used in non-pregnant women) is specifically recommended during pregnancy to minimize fetal exposure while maintaining efficacy. 2

High-Risk Asymptomatic Pregnant Women

Women with a history of previous preterm delivery who are found to have asymptomatic BV may benefit from screening and treatment, as this has reduced preterm delivery in three of four randomized controlled trials. 1

• Screen and treat at the first prenatal visit or earliest part of second trimester 2, 1, 2
• Use the same oral regimens as for symptomatic women 1
• Follow-up evaluation at 1 month after treatment completion is recommended to confirm cure 2, 1, 2

Low-Risk Asymptomatic Pregnant Women

Routine screening is not recommended for asymptomatic pregnant women without prior preterm birth history, as evidence does not support improved outcomes in this population. 3, 4, 5

Critical Medication Considerations in Pregnancy

What to Use:

• Oral metronidazole and oral clindamycin are safe throughout pregnancy 1, 6
• Multiple studies and meta-analyses have not demonstrated teratogenic or mutagenic effects from metronidazole use during pregnancy 1
• Systemic therapy is preferred over topical agents to treat possible subclinical upper genital tract infections 2, 1, 2

What to Avoid:

• Do NOT use clindamycin vaginal cream during pregnancy - three randomized trials showed increased adverse events including prematurity and neonatal infections after use of clindamycin cream 1, 2
• Metronidazole 2 g single-dose regimen was not effective in reducing preterm birth when studied in pregnancy 1
• Topical agents are not supported by existing data during pregnancy 1

Alternative Regimens (Less Preferred)

If oral metronidazole or clindamycin cannot be used:

• Metronidazole gel 0.75%, one full applicator intravaginally twice daily for 5 days (though data are limited in pregnancy) 2
• This should only be considered for symptomatic low-risk women when systemic therapy is not tolerated 2

Important Clinical Pitfalls

Partner treatment is NOT recommended - treatment of male sex partners does not affect cure rates or recurrence in pregnant women and is not part of standard care during pregnancy. 2, 1, 2 Note: Recent 2025 evidence in non-pregnant women suggests partner treatment may reduce recurrence 7, but this has not been studied or recommended for pregnant populations.

Avoid alcohol during metronidazole treatment and for 24 hours after completion. 1

Recurrence is common - if symptoms recur, retreatment with an alternative recommended regimen is appropriate. 2, 1, 2

Clinical Rationale

BV in pregnancy is associated with serious adverse outcomes including premature rupture of membranes, chorioamnionitis, preterm labor, preterm birth, postpartum endometritis, and post-cesarean wound infection. 1, 3, 4 The organisms characteristic of BV are frequently present in these complications, providing biological plausibility for treatment. 2